Atlas Trials

CD19-targeting CAR T Cells for B Cell Lymphoma

Clinical trial NCT02547948 · WITHDRAWN

Trial details

NCT number
NCT02547948
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
B Cell Lymphoma
Start date
2015-09-01
Primary completion
2016-08-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.